Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Pruritus Therapeutic Market Be Worth By 2029?

Over the past few years, there has been significant growth in the market size for pruritus therapeutics. It’s projected to enlarge from $14.29 billion in 2024 to $15.38 billion in 2025 with a compound annual growth rate (CAGR) of 7.6%. Factors such as the rising occurrence of pruritus, advancements in research and development, expanding senior population, improvements in healthcare infrastructure, increased patient awareness, and strategic collaborations and partnerships have all contributed to its growth during the historic period.

The market size for pruritus treatment is projected to experience robust expansion in the coming years. By 2029, it is predicted to reach a value of $21.88 billion, with a compound annual growth rate (CAGR) of 9.2%. Factors propelling this growth during the forecast period include ongoing research and innovation, burgeoning markets, escalating healthcare spending, the rise of personalized medicine, and regulatory encouragement of innovation. Major trends anticipated during the forecast period include the integration of telemedicine and digital health, technological advancements, telehealth and digital health solutions, the global regulatory landscape, biologics and immunomodulators, and patient-driven approaches.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

Which Key Factors Are Fueling Growth In The Pruritus Therapeutic Market?

The growth of the pruritus therapeutic market is significantly influenced by the escalating number of skin disorder cases. Skin conditions, also referred to as dermatological conditions or skin disorders, encompass issues like acne, eczema, skin cancer, psoriasis, and vitiligo that impact the skin. Pruritus therapeutics serve essential roles in the treatment of diverse skin diseases, given that pruritus is a key symptom in most skin disorders. For example, the American Academy of Dermatology Association, a US-based dermatology association, projected in April 2022 that melanoma is anticipated to result in the deaths of 7,650 individuals in 2022, including 5,080 men and 2,570 women. Furthermore, the American Cancer Society, a voluntary organization from the US, estimated in January 2023 that there would be 97,610 new melanoma diagnoses in 2023 in the United States, approximately 58,120 in men and 39,490 in women. Consequently, the rising prevalence of skin disorders is projected to fuel the pruritus therapeutic market’s expansion.

Which Segmentation Factors Are Critical In The Pruritus Therapeutic Market Analysis?

The pruritus therapeuticmarket covered in this report is segmented –

1) By Type: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressant; Calcineurin Inhibitors; Others Types

2) By Disease Type: Atopic Dermatitis Or Eczema; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types

3) By Application: External Use; Oral; Injection

4) By End Use: Hospitals; Clinics; Other Uses

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics; Injectable Local Anesthetics

4) By Counterirritants: Menthol-Based Products; Camphor-Based Products

5) By Immunosuppressants: Systemic Immunosuppressants; Topical Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus; Pimecrolimus

7) By Other Types: Antidepressants; Phototherapy Treatments; Herbal Remedies

What New Opportunities Are Emerging From Trends In The Pruritus Therapeutic Market?

The primary trend escalating in prominence within the pruritus therapeutic market is product innovation. The main players in the pruritus therapeutic market are concentrating on the development of new, cutting-edge medications and treatments for pruritus and its associated conditions. To illustrate, Maruho Co., Ltd., a pharmaceutical company based in Japan, unveiled the anti-IL-31 receptor, Mitchga Subcutaneous Injection 60 mg Syringes, in August 2022. It’s a pioneering humanized monoclonal antibody for the management of itchiness linked to atopic dermatitis. This drug holds the distinction of being the first antibody medication to impede IL-31 signaling, as IL-31 is a neuroimmune cytokine2 associated with pruritus, skin inflammation, and advancing atopic dermatitis3,4. Thus, this substance prevents IL-31 from binding to its receptor, subsequently halting itchiness and skin inflammation linked with atopic dermatitis.

Which Players Are Shaping The Competitive Landscape Of The Pruritus Therapeutic Market?

Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Pruritus Therapeutic Market?

North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9925&type=smp

Browse Through More Reports Similar to the Global Pruritus Therapeutic Market 2025, By The Business Research Company

Healthcare Nanotechnology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Healthcare Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-service-global-market-report

Home Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model